📍 2025 GHC Clinical Trials Webinar Series – Grand Finale 📍

Dear all,

As we look back on the journey we have taken together through the 2025 GHC Clinical Trials Webinar Series, we are truly grateful for the learning, dialogue, and global connections that each session has brought.
Now, the time has come to bring this meaningful year-long journey to a close — with our Grand Finale Session.

For this special closing session, we are deeply honored to welcome Dr. Jinho Shin from the WHO Regional Office for the Western Pacific (WPRO).

Dr. Shin has made significant contributions to advancing capacity-building and strengthening regulatory systems across countries through his dedicated work at WHO. His insights have fostered collaboration, mutual understanding, and a more cohesive regulatory community across the region.

Admired for his warm and gentlemanly communication style, Dr. Shin is an influential and trusted voice among regulatory authorities worldwide. We are confident that this final session will deliver valuable and inspiring takeaways for everyone who joins.

In this Grand Finale, Dr. Shin will guide us through the core concepts of the WHO-Listed Authority (WLA) framework in the context of clinical trials, and highlight key considerations for effective implementation at the national level, presented in a clear and practical manner.

“A session that has inspired regulators worldwide — one you won’t want to miss.”
“Join us for the Grand Finale with Dr. Jinho Shin — and let us close the 2025 GHC Clinical Trials
Webinar Series together.”

📅 Date & Time:
Tuesday, 18 November 2025 | 16:00–17:30 (KST) | Online Webinar (Zoom)

📝 Registration:
- Deadline: Monday, 17 November 2025
    - Fee: Free of charge
    - Certificate: will be available for attendees who complete the post-webinar survey

🔗 To Register:
https://lms.konect.or.kr/web/course/courseView.do?eduCd=K000000001202510230002&eduCertifiedYn=N&category1=